Pharmacist intervention in improving hypertension-related knowledge, treatment medication adherence and health-related quality of life: A non-clinical randomized controlled trial

Health Expectations

Volumn 18, Issue 5, 2015, Pages 1270-1281

  Saleem, Fahad ^a   Hassali, Mohamed A ^a   Shafie, Asrul A ^a   Ul Haq, Noman ^a   Farooqui, Maryam ^b   Aljadhay, Hisham ^c   Ahmad, Fiaz Ud Din ^a  

^a SCHOOL OF PHARMACEUTICAL SCIENCES   (Malaysia)

^b UNIVERSITI TEKNOLOGI MARA   (Malaysia)

^c KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Adherence; Hospital pharmacist; HRQoL; Hypertension; Intervention; Randomized controlled trial

Indexed keywords

ADOLESCENT; ADULT; ATTITUDE TO HEALTH; CONTROLLED STUDY; FEMALE; HEALTH CARE POLICY; HOSPITAL PERSONNEL; HOSPITAL PHARMACY; HUMAN; HYPERTENSION; MALE; MEDICATION COMPLIANCE; MIDDLE AGED; PAKISTAN; PATIENT EDUCATION; PHARMACIST; PROCEDURES; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; YOUNG ADULT;

ADOLESCENT; ADULT; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH POLICY; HUMANS; HYPERTENSION; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PAKISTAN; PATIENT EDUCATION AS TOPIC; PERSONNEL, HOSPITAL; PHARMACISTS; PHARMACY SERVICE, HOSPITAL; QUALITY OF LIFE; SURVEYS AND QUESTIONNAIRES; YOUNG ADULT;

EID: 84942292720     PISSN: 13696513     EISSN: 13697625     Source Type: Journal    
DOI: 10.1111/hex.12101     Document Type: Article

References (46)

1. World Health Organization. Global status report on non communicable diseases, 2010. Available at: http://www.who.int/nmh/publications/ncd_report_full_en.pdf, accessed 2 April 2012.
2. Ghaffar A, Reddy KS, Singhi M. Burden of non-communicable diseases in South Asia. British Medical Journal, 2004; 328: 807-810.
3. Nishtar S, Bile KM, Ahmed A, Amjad S, Iqbal A. Integrated population-based surveillance of noncommunicable diseases: the Pakistan model. American Journal of Preventive Medicine, 2005; 29: 102-106.
4. Sobani Z, Baloch H, Majeed A et al. Knowledge attitude and practices among urban women of Karachi, Pakistan, regarding breast cancer. Journal of Pakistan Medical Association, 2012; 62: 1259-1264.
5. Pakistan Medical Research Council 1998. National Health Survey of Pakistan, 1990-1994. Available at: http://www.pmrc.org.pk/researchactivities.htm, accessed 5 April 2012.
6. Godley P, Pham H, Rohack J, Woodward B, Yokoyama K, Maue SK. Opportunities for improving the quality of hypertension care in a managed care setting. American Journal of Health System Pharmacy, 2001; 58: 1728-1733.
7. Whitworth J. World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. Journal of Hypertension, 2003; 21: 1983-1992.
8. Saleem F, Hassali MA, Shafie AA, Awad AG, Bashir S. Association between knowledge and drug adherence in patients with hypertension in Quetta, Pakistan. Tropical Journal of Pharmaceutical Research, 2011; 10: 125-132.
9. Ogedegbe G. Barriers to optimal hypertension control. The Journal of Clinical Hypertension, 2008; 10: 644-646.
10. Amado Guirado E, Pujol Ribera E, Pacheco Huergo V, Borras JM. Knowledge and adherence to antihypertensive therapy in primary care: results of a randomized trial. Gaceta Sanitaria, 2011; 25: 62-67.
11. Haq NU, Hassali MA, Shafie AA, Saleem F, Farooqui M, Aljadhey H. A cross sectional assessment of knowledge, attitude and practice towards Hepatitis B among healthy population of Quetta, Pakistan. BMC Public Health, 2012; 12: 692.
12. Lachin JM, Matts JP, Wei L. Randomization in clinical trials: conclusions and recommendations. Controlled Clinical Trials, 1988; 9: 365-374.
13. Schulz KF, Grimes DA. Generation of allocation sequences in randomised trials: chance, not choice. Lancet, 2002; 359: 515-519.
14. Hopewell S, Dutton S, Yu LM, Chan AW, Altman DG. The quality of reports of randomised trials in 2000 and 2006: comparative study of articles indexed in PubMed. British Medical Journal, 2010; 340: c723.
15. National Bioethics Committee Pakistan. Ethical Research Committee-Guidelines, 2011. Available at: http://www.pmrc.org.pk/erc_guidelines.htm, accessed 8 April 2012.
16. Daniel WW. Biostatistics: Basic Concepts and Methodology for the Health Sciences. New York: John Wiley & Sons, 2010.
17. Roca B, Nadal E, Rovira RE, Valls S, Lapuebla C, Lloría N. Usefulness of a hypertension education program. Southern Medical Journal, 2003; 96: 1133-1137.
18. Viera AJ, Cohen LW, Mitchell CM, Sloane PD. High blood pressure knowledge among primary care patients with known hypertension: a North Carolina Family Medicine Research Network (NC-FM-RN) study. The Journal of the American Board of Family Medicine, 2008; 21: 300-308.
19. Voruganti L, Awad A. Neuroleptic dysphoria: towards a new synthesis. Psychopharmacology, 2004; 171: 121-132.
20. EuroQol Group. EuroQol-a new facility for the measurement of health-related quality of life. Health Policy, 1990; 16: 199-208.
21. Saleem F, Hassali MA, Shafie AA, Atif M, Awad AG. Predictors of medication adherence in a hypertensive population of Pakistan. Latin American Journal of Pharmacy, 2011; 30: 1714-1719.
22. Saleem F, Hassali M, Shafie A et al. Does treatment adherence correlates with health related quality of life? findings from a cross sectional study. BMC Public Health, 2012; 12: 318.
23. Behling O, Law KS. Translating Questionnaires and Other Research Instruments: Problems and Solutions. London, Thousand Oaks, CA: Sage Publications, 2000.
24. Harkness J, Schoua-Glusberg A. Questionnaires in translation. ZUMA-Nachrichten Spezial, 1998; 3: 87-126.
25. Saounatsou M, Patsi O, Fasoi G et al. The influence of the hypertensive patient's education in compliance with their medication. Public Health Nursing, 2002; 18: 436-442.
26. Steyn K. Overview and conclusions; A perspective on dealing with chronic diseases of lifestyle in South Africa. In: Steyn K, Fourie J, Temple N (eds) Chronic Diseases of Lifestyle in South Africa: 1995-2005, Technical Report, Cape Town: South African Medical Research Council, 2006. Available at: http://www.mrc.ac.za/chronic/cdl1995-2005.pdf, accessed 5 April 2012.
27. Gao X, Nau DP, Rosenbluth SA, Scott V, Woodward C. The relationship of disease severity, health beliefs and medication adherence among HIV patients. AIDS Care, 2000; 12: 387-398.
28. Horne R. One to be taken as directed: reflections on non-adherence (non-compliance). Journal of Social and Administrative Pharmacy, 1993; 10: 150-156.
29. Horne R. Patients' beliefs about treatment: the hidden determinant of treatment outcome? Journal of Psychosomatic Research, 1999; 47: 491-495.
30. Magadza C, Radloff S, Srinivas S. The effect of an educational intervention on patients' knowledge about hypertension, beliefs about medicines, and adherence. Research in Social and Administrative Pharmacy, 2009; 5: 363-375.
31. Population Association of Pakistan. Population characteristics, 2011. Available at: http://www.pap.org.pk/statistics/population.htm, accessed 10 April 2012.
32. Peters KF, Horne R, Kong F, Francomano CA, Biesecker BB. Living with Marfan syndrome II. Medication adherence and physical activity modification. Clinical Genetics, 2002; 60: 283-292.
33. Viswanathan H, Anderson R, Thomas J III. Evaluation of an antiretroviral medication attitude scale and relationships between medication attitudes and medication nonadherence. AIDS Patient Care & STDs, 2005; 19: 306-316.
34. Chabot I, Moisan J, Grégoire JP, Milot A. Pharmacist intervention program for control of hypertension. Annals of Pharmacotherapy, 2003; 37: 1186-1193.
35. Gusmão JL, Mion D Jr, Pierin A. Health-related quality of life and blood pressure control in hypertensive patients with and without complications. Clinics, 2009; 64: 619-628.
36. Li W, Liu L, Puente JG et al. Hypertension and health-related quality of life: an epidemiological study in patients attending hospital clinics in China. Journal of Hypertension, 2005; 23: 1667-1676.
37. Wang R, Zhao Y, He X et al. Impact of hypertension on health-related quality of life in a population-based study in Shanghai, China. Public Health, 2009; 123: 534-539.
38. Ogunlana MO, Adedokun B, Dairo MD, Odunaiya NA. Profile and predictor of health-related quality of life among hypertensive patients in south-western Nigeria. BMC Cardiovascular Disorders, 2009; 9: 25.
39. Cavalcante MA, Bombig MT, Luna Filho B, Carvalho AC, Paola AA, Póvoa R. Quality of life of hypertensive patients treated at an outpatient clinic. Arquivos Brasileiros de Cardiologia, 2007; 89: 245-250.
40. Soni RK, Weisbord SD, Unruh ML. Health-related quality of life outcomes in chronic kidney disease. Current Opinion in Nephrology and Hypertension, 2010; 19: 153-159.
41. Côté I, Moisan J, Chabot I, Grégoire JP. Health-related quality of life in hypertension: impact of a pharmacy intervention programme. Journal of Clinical Pharmacy and Therapeutics, 2005; 30: 355-362.
42. Shahina PT, Revikumar KG, Krishnan R, Jaleel VA, Shini VK. The impact of pharmacist interventions on quality of life in patients with hypertension. International Journal of Pharmaceutical Sciences Review and Research, 2010; 5: 172-176.
43. Borgaonkar MR, Townson G, Donnelly M, Irvine EJ. Providing disease-related information worsens health-related quality of life in inflammatory bowel disease. Inflammatory Bowel Diseases, 2006; 8: 264-269.
44. Mayberry J, Rose J, Rhodes J. Assessment of a patient information booklet on ulcerative colitis. Italian Journal of Gastroenterology, 1989; 21: 193-195.
45. Martin A, Leone L, Castagliuolo I, Di Mario F, Naccarato R. What do patients want to know about their inflammatory bowel disease? Italian Journal of Gastroenterology, 1992; 24: 477-480.
46. Taichman DB, Shin J, Hud L et al. Health-related quality of life in patients with pulmonary arterial hypertension. Respiratory Research, 2005; 6: 92.